Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
On 24 October 2015, during the HFA Summit, members of the Heart Failure Association Board and national Heart Failure Working Group Presidents signed a declaration designed to unanimously adopt a Call For Action in support of the HFA's Global Heart Failure Awareness Programme.
The HFA, the world’s largest Heart Failure organisation and Heart Failure Working Groups from National Cardiac Societies join forces to recommend united action, and declare that they believe that the global burden of heart failure is huge, and cannot be allowed to continue unchallenged. Preventing Heart Failure must become a strategic health priority for each and every country
Consult the HFA White Paper "Heart failure: Preventing disease and death worldwide".
The White Paper aims to demonstrate the burden of the disease with a clear Call to Action which includes the establishment of a systematic approach to identifying target groups at risk from Heart Failure and appropriate prevention and treatment modalities which could serve as the basis for future international guidelines.
It has been distributed and presented to National Heart Failure Societies and Working Groups worldwide at the Endorsement Meeting that took place in Athens on 16 May 2014.
Chinese Society for Thoracic and Cardiovascular Surgery
Republic of Serbia
Heart Failure Society of America
Listen to Prof Petar Seferovic (Belgrade, RS) and Prof Piotr Ponikowski (Wroslaw, PL) discussing the aims and challenges of the Heart Failure Global Awareness Programme.
The complexity of the Heart Failure syndrome represents a major obstacle to adequate identification and diagnosis of untreated patients. But this also thwarts understanding of heart failure among politicians and the general public.
Heart Failure awareness among healthcare professionals and non-medics is poor across the globe, in contrast to the recognition of cancer which is related to the global campaign oncologists have been conducting for some time.
The publication of the 'Acute Heart Failure Report - Improving Care for Patients with Acute Heart Failure'. The recommendations contained in this report have been endorsed and adopted by the Heart Failure Association of the European Society of Cardiology as part of their Global Heart Failure Awareness Programme.
15:30 Welcome and introduction - Prof. Stefan D. Anker
15:35 About the Global Heart Failure Awareness Programme - Prof. P. Ponikowski
15: 40 Improving care for patients with acute heart failure: before during and after hospitalization - Prof. M.R. Cowie
© 2014 Oxford PharmaGenesis™Made available with permission from Oxford PharmaGenesis™ Ltd. Based on Cowiehttp://www.oxfordhealthpolicyforum.org/AHFreport et al., Improving care for patients with acute heart failure: before, during and after hospitalization, 2014, Oxford, UK. Available from:
15:50 Heart failure: preventing disease and death worldwide - Prof. G. Filippatos
16:00 Regional perspectives - Dr. K.F. AlHabib - Prof. T.L. Force - Prof. H. Krum - Dr. V. Rastogi - Prof. L.E. Rohde - Prof. B.B. Siswanto - Prof. K. Sliwa
16:40 Future plans - Prof. P. Ponikowski
Read the meeting reportThe Global Heart Failure Awareness Programme is supported by Novartis Pharma AG and SERVIER in the form of an unrestricted educational grant.
© 2017 European Society of Cardiology. All rights reserved